Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022)
Kodiak Sciences (KOD) reported Amortization of Deferred Charges of $1.9 million for Q1 2022, down 2.76% on a YoY basis from $2.0 million in Q1 2021, and little changed quarter-over-quarter from $1.9 million in Q4 2021.
Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022) Analysis & Trends
Kodiak Sciences has reported Amortization of Deferred Charges for 6 years, with the latest figure at $1.9 million in Q1 2022.
- For the quarter ending Q1 2022, Amortization of Deferred Charges fell 2.76% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2022 stood at $7.7 million (up 36.9% YoY), and the FY2021 full-year result was $7.7 million, up 106.59% from the prior year.
- Amortization of Deferred Charges for Q1 2022 stood at $1.9 million, roughly flat from $1.9 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $2.0 million in Q1 2021, with the low at $90000.0 in Q1 2019.
- Historically, Amortization of Deferred Charges has averaged $1.0 million across 5 years, with a median of $1.5 million in 2018.
- Annual changes were most pronounced in 2019 — Amortization of Deferred Charges plunged 95.08% — and 2021, when it surged 1897.96%.
- Kodiak Sciences' Amortization of Deferred Charges stood at $187000.0 in 2018, then plunged by 48.13% to $97000.0 in 2019, then surged by 1897.94% to $1.9 million in 2020, then decreased by 2.12% to $1.9 million in 2021, then gained by 0.37% to $1.9 million in 2022.
- The last three Amortization of Deferred Charges figures came in at $1.9 million (Q1 2022), $1.9 million (Q4 2021), and $1.9 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Mar 31, 2021 | 1.96 Mn |
| Mar 31, 2021 | 1.96 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.59 Mn |
| Jun 30, 2020 | 101,000.00 |
| Jun 30, 2020 | 101,000.00 |
| Mar 31, 2020 | 98,000.00 |
| Mar 31, 2020 | 98,000.00 |
| Dec 31, 2019 | 97,000.00 |
| Dec 31, 2019 | 97,000.00 |